BKD:NYE-Brookdale Senior Living Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 6.41

Change

0.00 (0.00)%

Market Cap

USD 2.25B

Volume

2.62M

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Brookdale Senior Living Inc is an operator of senior living communities in the United States with a total capacity of approximately 143 communities in 46 states and the ability to serve approximately 111,000 residents.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+2.81 (+0.83%)

USD 89.22B
THC Tenet Healthcare Corporation

+2.61 (+1.92%)

USD 13.29B
UHS Universal Health Services Inc

+1.89 (+1.00%)

USD 12.78B
DVA DaVita HealthCare Partners Inc

-0.71 (-0.50%)

USD 12.08B
FMS Fresenius Medical Care Corpora..

+0.07 (+0.37%)

USD 11.24B
EHC Encompass Health Corp

+1.27 (+1.50%)

USD 8.59B
CHE Chemed Corp

+3.71 (+0.69%)

USD 8.16B
SEM Select Medical Holdings

+1.23 (+3.63%)

USD 4.47B
AGL agilon health Inc

+0.04 (+0.61%)

USD 2.69B
AMN AMN Healthcare Services Inc

-1.75 (-3.27%)

USD 2.02B

ETFs Containing BKD

DXSD:F 10.59 % 0.00 %

N/A

N/A
DXSD:XETRA 10.59 % 0.00 %

N/A

N/A
ESIE:XETRA iShares MSCI Europe Energ.. 8.88 % 0.00 %

+0.06 (+0.00%)

USD 0.15B
EYED:LSE iShares MSCI Europe Energ.. 8.79 % 0.00 %

+0.03 (+0.00%)

USD 0.02B
STN:PA SPDR® MSCI Europe Energy.. 7.93 % 0.00 %

+1.10 (+0.00%)

USD 1.07B
SPYN:F SSgA SPDR ETFs Europe II .. 7.93 % 0.00 %

+0.90 (+0.00%)

USD 1.07B
SPYN:XETRA SPDR® MSCI Europe Energy.. 7.93 % 0.00 %

+1.20 (+0.00%)

USD 0.99B
STNX:SW SPDR® MSCI Europe Energy.. 7.93 % 0.00 %

+1.55 (+0.00%)

USD 1.07B
ENGY:LSE SPDR® MSCI Europe Energy.. 7.87 % 0.00 %

+0.83 (+0.00%)

USD 1.09B
ENGE:LSE SPDR® MSCI Europe Energy.. 7.87 % 0.00 %

N/A

USD 1.10B
FMI:PA Amundi Index Solutions - .. 7.78 % 0.00 %

-0.84 (0.00%)

USD 0.07B
SXRY:F iShares FTSE MIB UCITS 6.20 % 0.00 %

N/A

USD 0.23B
SXRY:XETRA iShares FTSE MIB UCITS 6.20 % 0.00 %

-1.56 (0.00%)

USD 0.21B
CSMIB:SW iShares VII PLC - iShares.. 6.20 % 0.00 %

N/A

USD 0.22B
MIB:PA Lyxor FTSE MIB (DR) UCITS.. 6.20 % 0.00 %

-0.39 (0.00%)

USD 0.46B
EXH1:F iShares STOXX Europe 600 .. 6.19 % 0.00 %

N/A

USD 0.49B
EXH1:XETRA iShares STOXX Europe 600 .. 6.19 % 0.00 %

+0.07 (+0.00%)

USD 0.73B
SXEPEX:SW iShares STOXX Europe 600 .. 6.19 % 0.00 %

N/A

USD 0.08B
DBXI:XETRA Xtrackers FTSE MIB UCITS .. 6.15 % 0.00 %

-0.34 (0.00%)

USD 0.05B
CMB1:LSE iShares FTSE MIB UCITS 6.02 % 0.00 %

-143.00 (0.00%)

USD 0.22B
EWI iShares MSCI Italy ETF 4.45 % 0.47 %

-0.31 (0.00%)

USD 0.42B
XD3E:LSE Xtrackers Euro Stoxx Qual.. 4.08 % 0.00 %

-11.30 (0.00%)

USD 0.25B
DXSA:F Xtrackers - Euro Stoxx Se.. 3.29 % 0.00 %

-0.12 (0.00%)

USD 0.25B
DXSA:XETRA Xtrackers - Euro Stoxx Se.. 3.29 % 0.00 %

-0.13 (0.00%)

USD 0.26B
UC14:LSE UBS (Irl) Fund Solutions .. 3.07 % 0.00 %

+0.57 (+0.00%)

USD 1.09B
UC15:LSE UBS (Irl) Fund Solutions .. 3.07 % 0.00 %

+32.00 (+0.00%)

USD 1.09B
UC90:LSE UBS (Irl) Fund Solutions .. 3.07 % 0.00 %

+67.50 (+0.00%)

USD 0.01B
UIQI:F UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

N/A

USD 0.31B
UIQI:XETRA UBSs plc - MSCI AC Asia E.. 3.04 % 0.00 %

-0.28 (0.00%)

USD 0.31B
AJEUAS:SW UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

-1.14 (0.00%)

N/A
WTEE:F WisdomTree Europe Equity .. 2.04 % 0.00 %

-0.15 (0.00%)

USD 0.03B
EEI:SW WisdomTree Europe Equity .. 2.04 % 0.00 %

-0.06 (0.00%)

N/A
EEIA:SW WisdomTree Europe Equity .. 2.04 % 0.00 %

N/A

USD 4.78M
FYC First Trust Small Cap Gro.. 0.00 % 0.70 %

+0.52 (+0.00%)

USD 0.27B
IMIB:LSE iShares FTSE MIB UCITS Di.. 0.00 % 0.00 %

-19.10 (0.00%)

USD 0.14B
WTEE:XETRA WisdomTree Europe Equity .. 0.00 % 0.00 %

-0.08 (0.00%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.14% 52% F 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.14% 52% F 73% C
Trailing 12 Months  
Capital Gain 64.36% 86% B+ 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.36% 86% B+ 95% A
Trailing 5 Years  
Capital Gain -1.99% 33% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.99% 33% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain 18.52% 77% C+ 83% B
Dividend Return 18.52% 77% C+ 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 75.39% 27% F 10% F
Risk Adjusted Return 24.56% 50% F 47% F
Market Capitalization 2.25B 50% F 58% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.36 16% 22%
Price/Book Ratio 3.03 48% 28%
Price / Cash Flow Ratio 7.72 38% 48%
Price/Free Cash Flow Ratio 14.04 30% 28%
Management Effectiveness  
Return on Equity -38.00% 14% 10%
Return on Invested Capital 0.23% 36% 25%
Return on Assets 0.43% 33% 25%
Debt to Equity Ratio 905.67% 14% 3%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector